GEA Pharma Systems was formed early in the year 2000 after GEA Group acquired the pharmaceutical division of GEI International. The newly acquired brands BuckŪ - containment interfaces solutions and Buck Systems™ - contained materials handling, Collette™ - continuous granulation & single pot technology, Courtoy™ - tablet compression, were combined into GEA Pharma Systems along with the existing GEA brands, Aeromatic-Fielder ™ and NICA™- granulation, drying, pelletizing and coating.
With this combination, GEA Pharma Systems became the leading international supplier of advanced processing technologies for the manufacturing of oral and parenteral dosage forms for the pharmaceutical industry.
In November 2005 followed the acquisition of the lyophilization business of Steris Gmbh by GEA Group and the renaming of the company into GEA Lyophil it joined the other pharma brands in GEA Pharma Systems. GEA Lyophil supplies specialist freeze drying technology for the pharmaceutical and biotechnology markets.
GEA Pharma Systems’ activities include partnering with customers to develop new products and enhance clinical effectiveness; the supply of R&D-scale and stand-alone production equipment; and the installation of complete integrated production lines.
Innovation - Tomorrow’s technology today
For GEA Pharma Systems, innovation is the key to our success and to continued prosperity for our customers. In fact it’s more than that. We know that by continually stretching the boundaries of what is possible in pharmaceutical processing we have the ability to support our Customers in enhancing the opportunities available to millions of people all over the world. This is what drives our business.
Our innovation takes many forms and affects all parts of the process. We innovate to increase production and reduce costs, to improve containment and safeguard the workforce, to achieve better clinical effectiveness and to enhance quality control. At GEA Pharma Systems the innovation never stops – it’s just part of what we do.
For example we have pioneered Pharma spray drying to provide unprecedented control of particle form and release profile for drug development, meeting the most demanding clinical needs. FlexStream™ (patent pending): our new fluid bed coating system offers multiple processing from a single bowl providing both flexibility and cost benefits. MODUL™ and PERFORMA™ tablet presses combine unrivalled containment with fast product change-over and high productivity. The BuckŪ MC Valve makes the contained handling of active pharmaceutical ingredients much easier and less expensive than has been possible in the past. Consigma™: a unique continuous granulation, drying and tableting process that drastically reduces time to market of new medicines and enables the move to a 6-Sigma process; and PharmaConnect™ which enables diverse GEA development equipment to be docked into a single ‘plug and play’ module with full cGMP compliance.
Innovation - not just for its own sake but for improved products, greater safety and enhanced productivity to deliver a better future.
Under the following links you can discover a more indepth corporate history of the individual brands that make up GEA Pharma Systems: